Regulation of the cellular redox state and the expression of DNA methyltransferase-1 in peripheral blood mononuclear cells from patients with Graves’ disease

Abstract: Background: Graves’ disease is an autoimmune disorder characterised by excessive production of thyroid hormones, which induces increased cellular metabolism in most tissues and increased production of reactive oxygen species (ROS). The aim of this work was to analyse the effect of ROS on cell viability and the expression of catalase (CAT), glutathione peroxidase-1 (GPx1), superoxide dismutase (SOD-1) and DNA methyltransferase-1 (DNMT-1) in peripheral blood mononuclear cells (PBMC) from patients with newly diagnosed Graves’ disease or treated with methimazole. Patients and methods: For this study, women patients with newly diagnosed Graves’ disease (n = 18), treated with methimazole (n = 6) and healthy subjects (n = 15) were recruited. ROS were evaluated by flow cytometry, and the viability/apoptosis of PBMC was analysed by flow cytometry and fluorescence microscopy. Genomic expression of CAT, GPx-1, SOD-1 and DNMT-1 was quantified by real-time PCR. Results: We found high levels of ROS and increased expression of CAT, GPx-1, SOD-1 and DNMT-1 in PBMC from patients with newly diagnosed Graves’ disease. Methimazole treatment reversed these parameters. Cell viability was similar in all study groups. Conclusions: ROS induces the expression of CAT, GPx-1, and SOD-1. The activity of these enzymes may contribute to the protection of PBMC from the harmful effect of free radicals on cell viability. Increased expression of DNMT-1 may be associated with aberrant methylation patterns in immunoregulatory genes contributing to autoimmunity in Graves’ disease.

Saved in:
Bibliographic Details
Main Authors: Saban, Melina, Costilla, Melisa, Klecha, Alicia Juana, Di Cugno, Mariana, Curriá, Marina Inés, Cremaschi, Graciela A., Barreiro Arcos, María Laura
Format: Artículo biblioteca
Language:eng
Published: Elsevier 2021
Subjects:ENFERMEDAD DE GRAVES, CELULAS MONONUCLEARES DE SANGRE PERIFÉRICA, ESTRES OXIDATIVO, ENZIMAS ANTIOXIDANTES, ADN METILTRANSFERASA-1,
Online Access:https://repositorio.uca.edu.ar/handle/123456789/14017
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:ucacris:123456789-14017
record_format koha
institution UCA
collection DSpace
country Argentina
countrycode AR
component Bibliográfico
access En linea
databasecode dig-uca
tag biblioteca
region America del Sur
libraryname Sistema de bibliotecas de la UCA
language eng
topic ENFERMEDAD DE GRAVES
CELULAS MONONUCLEARES DE SANGRE PERIFÉRICA
ESTRES OXIDATIVO
ENZIMAS ANTIOXIDANTES
ADN METILTRANSFERASA-1
ENFERMEDAD DE GRAVES
CELULAS MONONUCLEARES DE SANGRE PERIFÉRICA
ESTRES OXIDATIVO
ENZIMAS ANTIOXIDANTES
ADN METILTRANSFERASA-1
spellingShingle ENFERMEDAD DE GRAVES
CELULAS MONONUCLEARES DE SANGRE PERIFÉRICA
ESTRES OXIDATIVO
ENZIMAS ANTIOXIDANTES
ADN METILTRANSFERASA-1
ENFERMEDAD DE GRAVES
CELULAS MONONUCLEARES DE SANGRE PERIFÉRICA
ESTRES OXIDATIVO
ENZIMAS ANTIOXIDANTES
ADN METILTRANSFERASA-1
Saban, Melina
Costilla, Melisa
Klecha, Alicia Juana
Di Cugno, Mariana
Curriá, Marina Inés
Cremaschi, Graciela A.
Barreiro Arcos, María Laura
Regulation of the cellular redox state and the expression of DNA methyltransferase-1 in peripheral blood mononuclear cells from patients with Graves’ disease
description Abstract: Background: Graves’ disease is an autoimmune disorder characterised by excessive production of thyroid hormones, which induces increased cellular metabolism in most tissues and increased production of reactive oxygen species (ROS). The aim of this work was to analyse the effect of ROS on cell viability and the expression of catalase (CAT), glutathione peroxidase-1 (GPx1), superoxide dismutase (SOD-1) and DNA methyltransferase-1 (DNMT-1) in peripheral blood mononuclear cells (PBMC) from patients with newly diagnosed Graves’ disease or treated with methimazole. Patients and methods: For this study, women patients with newly diagnosed Graves’ disease (n = 18), treated with methimazole (n = 6) and healthy subjects (n = 15) were recruited. ROS were evaluated by flow cytometry, and the viability/apoptosis of PBMC was analysed by flow cytometry and fluorescence microscopy. Genomic expression of CAT, GPx-1, SOD-1 and DNMT-1 was quantified by real-time PCR. Results: We found high levels of ROS and increased expression of CAT, GPx-1, SOD-1 and DNMT-1 in PBMC from patients with newly diagnosed Graves’ disease. Methimazole treatment reversed these parameters. Cell viability was similar in all study groups. Conclusions: ROS induces the expression of CAT, GPx-1, and SOD-1. The activity of these enzymes may contribute to the protection of PBMC from the harmful effect of free radicals on cell viability. Increased expression of DNMT-1 may be associated with aberrant methylation patterns in immunoregulatory genes contributing to autoimmunity in Graves’ disease.
format Artículo
topic_facet ENFERMEDAD DE GRAVES
CELULAS MONONUCLEARES DE SANGRE PERIFÉRICA
ESTRES OXIDATIVO
ENZIMAS ANTIOXIDANTES
ADN METILTRANSFERASA-1
author Saban, Melina
Costilla, Melisa
Klecha, Alicia Juana
Di Cugno, Mariana
Curriá, Marina Inés
Cremaschi, Graciela A.
Barreiro Arcos, María Laura
author_facet Saban, Melina
Costilla, Melisa
Klecha, Alicia Juana
Di Cugno, Mariana
Curriá, Marina Inés
Cremaschi, Graciela A.
Barreiro Arcos, María Laura
author_sort Saban, Melina
title Regulation of the cellular redox state and the expression of DNA methyltransferase-1 in peripheral blood mononuclear cells from patients with Graves’ disease
title_short Regulation of the cellular redox state and the expression of DNA methyltransferase-1 in peripheral blood mononuclear cells from patients with Graves’ disease
title_full Regulation of the cellular redox state and the expression of DNA methyltransferase-1 in peripheral blood mononuclear cells from patients with Graves’ disease
title_fullStr Regulation of the cellular redox state and the expression of DNA methyltransferase-1 in peripheral blood mononuclear cells from patients with Graves’ disease
title_full_unstemmed Regulation of the cellular redox state and the expression of DNA methyltransferase-1 in peripheral blood mononuclear cells from patients with Graves’ disease
title_sort regulation of the cellular redox state and the expression of dna methyltransferase-1 in peripheral blood mononuclear cells from patients with graves’ disease
publisher Elsevier
publishDate 2021
url https://repositorio.uca.edu.ar/handle/123456789/14017
work_keys_str_mv AT sabanmelina regulationofthecellularredoxstateandtheexpressionofdnamethyltransferase1inperipheralbloodmononuclearcellsfrompatientswithgravesdisease
AT costillamelisa regulationofthecellularredoxstateandtheexpressionofdnamethyltransferase1inperipheralbloodmononuclearcellsfrompatientswithgravesdisease
AT klechaaliciajuana regulationofthecellularredoxstateandtheexpressionofdnamethyltransferase1inperipheralbloodmononuclearcellsfrompatientswithgravesdisease
AT dicugnomariana regulationofthecellularredoxstateandtheexpressionofdnamethyltransferase1inperipheralbloodmononuclearcellsfrompatientswithgravesdisease
AT curriamarinaines regulationofthecellularredoxstateandtheexpressionofdnamethyltransferase1inperipheralbloodmononuclearcellsfrompatientswithgravesdisease
AT cremaschigracielaa regulationofthecellularredoxstateandtheexpressionofdnamethyltransferase1inperipheralbloodmononuclearcellsfrompatientswithgravesdisease
AT barreiroarcosmarialaura regulationofthecellularredoxstateandtheexpressionofdnamethyltransferase1inperipheralbloodmononuclearcellsfrompatientswithgravesdisease
AT sabanmelina regulaciondelestadoredoxcelularylaexpresiondeadnmetiltransferasa1encelulasmononuclearesdesangreperifericadepacientesconenfermedaddegraves
AT costillamelisa regulaciondelestadoredoxcelularylaexpresiondeadnmetiltransferasa1encelulasmononuclearesdesangreperifericadepacientesconenfermedaddegraves
AT klechaaliciajuana regulaciondelestadoredoxcelularylaexpresiondeadnmetiltransferasa1encelulasmononuclearesdesangreperifericadepacientesconenfermedaddegraves
AT dicugnomariana regulaciondelestadoredoxcelularylaexpresiondeadnmetiltransferasa1encelulasmononuclearesdesangreperifericadepacientesconenfermedaddegraves
AT curriamarinaines regulaciondelestadoredoxcelularylaexpresiondeadnmetiltransferasa1encelulasmononuclearesdesangreperifericadepacientesconenfermedaddegraves
AT cremaschigracielaa regulaciondelestadoredoxcelularylaexpresiondeadnmetiltransferasa1encelulasmononuclearesdesangreperifericadepacientesconenfermedaddegraves
AT barreiroarcosmarialaura regulaciondelestadoredoxcelularylaexpresiondeadnmetiltransferasa1encelulasmononuclearesdesangreperifericadepacientesconenfermedaddegraves
_version_ 1756276524199182336
spelling oai:ucacris:123456789-140172022-05-25T05:00:53Z Regulation of the cellular redox state and the expression of DNA methyltransferase-1 in peripheral blood mononuclear cells from patients with Graves’ disease Regulación del estado redox celular y la expresión de ADN metiltransferasa-1 en células mononucleares de sangre periférica de pacientes con enfermedad de Graves Saban, Melina Costilla, Melisa Klecha, Alicia Juana Di Cugno, Mariana Curriá, Marina Inés Cremaschi, Graciela A. Barreiro Arcos, María Laura ENFERMEDAD DE GRAVES CELULAS MONONUCLEARES DE SANGRE PERIFÉRICA ESTRES OXIDATIVO ENZIMAS ANTIOXIDANTES ADN METILTRANSFERASA-1 Abstract: Background: Graves’ disease is an autoimmune disorder characterised by excessive production of thyroid hormones, which induces increased cellular metabolism in most tissues and increased production of reactive oxygen species (ROS). The aim of this work was to analyse the effect of ROS on cell viability and the expression of catalase (CAT), glutathione peroxidase-1 (GPx1), superoxide dismutase (SOD-1) and DNA methyltransferase-1 (DNMT-1) in peripheral blood mononuclear cells (PBMC) from patients with newly diagnosed Graves’ disease or treated with methimazole. Patients and methods: For this study, women patients with newly diagnosed Graves’ disease (n = 18), treated with methimazole (n = 6) and healthy subjects (n = 15) were recruited. ROS were evaluated by flow cytometry, and the viability/apoptosis of PBMC was analysed by flow cytometry and fluorescence microscopy. Genomic expression of CAT, GPx-1, SOD-1 and DNMT-1 was quantified by real-time PCR. Results: We found high levels of ROS and increased expression of CAT, GPx-1, SOD-1 and DNMT-1 in PBMC from patients with newly diagnosed Graves’ disease. Methimazole treatment reversed these parameters. Cell viability was similar in all study groups. Conclusions: ROS induces the expression of CAT, GPx-1, and SOD-1. The activity of these enzymes may contribute to the protection of PBMC from the harmful effect of free radicals on cell viability. Increased expression of DNMT-1 may be associated with aberrant methylation patterns in immunoregulatory genes contributing to autoimmunity in Graves’ disease. Resumen: Antecedentes: La enfermedad de Graves es un trastorno autoinmune caracterizado por una producción excesiva de hormonas tiroideas, que induce un aumento del metabolismo celular en la mayoría de los tejidos y una mayor producción de especies reactivas de oxígeno (ROS). El objetivo de este trabajo fue analizar el efecto de las ROS sobre la viabilidad celular y la expresión de catalasa (CAT), glutatión peroxidasa-1 (GPx-1), superóxido dismutasa (SOD-1) y ADN metiltransferasa-1 (DNMT-1) en células mononucleares de sangre periférica (PBMC) de pacientes con enfermedad de Graves recién diagnosticada o tratados con metimazol. Pacientes y métodos: Se seleccionó a mujeres con enfermedad de Graves recién diagnosticada (n = 18), tratadas con metimazol (n = 6) y a sujetos sanos (n = 15). La producción de ROS fue evaluada por citometría de flujo. La viabilidad y apoptosis de las PBMC fue analizada por citometría de flujo y microscopía de fluorescencia. La expresión genómica de CAT, GPx-1, SOD-1 y DNMT-1 fue cuantificada por PCR en tiempo real. Resultados: Encontramos altos niveles de ROS y una mayor expresión de CAT, GPx-1, SOD-1 y DNMT-1 en PBMC de pacientes con enfermedad de Graves recién diagnosticada. El tratamiento con metimazol revirtió estos parámetros. La viabilidad celular fue similar en todos los grupos de estudio. Conclusiones: Las ROS inducen la expresión de CAT, GPx-1 y SOD-1. La actividad de estas enzimas podría contribuir a la protección de las PBMC del efecto nocivo de los radicales libres sobre la viabilidad celular. El aumento de la expresión de DNMT-1 podría estar asociado con patrones de metilación aberrantes en genes inmunorreguladores que contribuyen a la autoinmunidad en la enfermedad de Graves. 2022-05-24T12:05:49Z 2022-05-24T12:05:49Z 2021 Artículo Saban, M. et al. Regulation of the cellular redox state and the expression of DNA methyltransferase-1 in peripheral blood mononuclear cells from patients with Graves’ disease [en línea]. Endocrinología, Diabetes y Nutrición. 2021. doi: https://doi.org/10.1016/j.endinu.2021.07.011. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/14017 2530-0164 (online) https://repositorio.uca.edu.ar/handle/123456789/14017 10.1016/j.endinu.2021.07.011 eng Mecanismos epigenéticos involucrados en la funcionalidad del sistema inmune en pacientes con hipertiroidismo de graves. Participación del estrés oxidativo Acceso abierto http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf Elsevier Endocrinología, Diabetes y Nutrición, 2021